Articles

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

17.12.2014 BE law

Team

Related news

14.10.2021 NL law
NFTs: New legal challenges on the horizon

Short Reads - Non-Fungible Tokens, widely known as NFTs, have recently gained much attention due to their role in the transfer of digital artworks. The market for NFTs grew from USD 13.5m in the first six months of 2020 to USD 2.5bn in the first half of 2021 and is still growing at an expansive rate. Notwithstanding their increasing popularity in the world of art, NFTs have many potential applications. In this blog Maciek Bednarski, Annemijn Witkam and Roderik Vrolijk explain what NFTs are and describe some of the legal challenges they will bring about.

Read more